Le produit a bien été ajouté au panier.

discount label
H-SIINF^EKL-OH
Vue en 3D

Biosynth logo

H-SIINF^EKL-OH

Ref. 3D-PP48994

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le vendredi 13 décembre 2024

Informations sur le produit

Nom :
H-SIINF^EKL-OH
Description :

Peptide H-SIINF^EKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIINF^EKL-OH include the following: A supramolecular vaccine platform based on alpha-helical peptide nanofibers Y Wu , PK Norberg, EA Reap , KL Congdon - ACS biomaterials , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.7b00561 Peptide-based cancer vaccine delivery via the STINGΔTM-cGAMP complex Y He , C Hong , SJ Fletcher, AG Berger - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202200905 Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry SC Uslu , UJ Lee , S Tavakolpour - ACS Pharmacology & , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsptsci.3c00268 Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv , K Song , A Yen , DJ Peeler - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101651 Cutting edge: N-hydroxy peptides: a new class of TCR antagonists S Hin, C Zabel, A Bianco , G Jung - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2363/32894 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Exact prediction of a natural T cell epitope O Rötzschke , K Falk, S Stevanovic - European journal of , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830211136 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V Böhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells NA Kukutsch, S Rossner, JM Austyn, G Schuler - Journal of investigative , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15409935 Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel M Kamalov , H Kahlig, C Rentenberger, ARM Mullner - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-019-39148-8 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL M Gonciarz-Swiatek, M Rechsteiner - Molecular immunology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589005004104 Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH-sensitive liposomes encapsulated with Kb-restricted CTL epitope KY Lee, E Chun , BL Seong - Biochemical and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02967112 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 MHC/peptide binding studies indicate hierarchy of anchor residues K Deres, W Beck, S Faath, G Jung, HG Rammensee - Cellular immunology, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712281 Brucella peptide cross-reactive major histocompatibility complex class I presentation activates SIINFEKL-specific T cell receptor-expressing T cells JS Harms, M Khan, C Hall , GA Splitter - Infection and , 2018 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.00281-18 Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase J Beninga, KL Rock, AL Goldberg - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)80196-X/abstract In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability GB Lipford , S Bauer, H Wagner , K Heeg - Vaccine, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0264410X95933209 A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules E Schott, N Bertho , Q Ge - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.212515399 Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics D Dersh , JW Yewdell , J Wei - Antigen Processing: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9450-2_9 Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) CL Nguyen, ML Salem , MP Rubinstein, M Demcheva - Vaccine, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X03000963 Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum CJ Hilton , AM Dahl, KL Rock - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/166/6/3952/70418 Anti-Peptide Antibody Blocks Peptide CJ Hilton , AM Dahl, KL Rock - scholar.archive.orghttps://scholar.archive.org/work/c72ogauyunfuhgex7k36gpd7w4/access/wayback/http://www.umassmed.edu/uploadedFiles/otm2/Ready_to_sign/00-32%20Ref.pdf A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma C Capasso, A Magarkar , V Cervera-Carrascon - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1319028 T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Functional screening of a retroviral peptide library for MHC class I presentation AB Tolstrup, M Duch, I Dalum, FS Pedersen - Gene, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378111900005722 Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody A Porgador , JW Yewdell , Y Deng, JR Bennink - Immunity, 1997 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(00)80447-1.pdf Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC aca– Met, S Buus , MH Claesson - Cellular immunology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000887490300128X pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects A Faham, T Herringson, C Parish, A Suhrbier - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11010772 Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850 Analysis of the proteolytic steps involved in MHC class I presentation of the ovalbumin epitope SIINFEKL A Craiu - 1997 - search.proquest.comhttps://search.proquest.com/openview/dc58025ab6af04f400622af0d7a743d2/1?pq-origsite=gscholar&cbl=18750&diss=y Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis A Carambia, C Gottwick, D Schwinge, S Stein - , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.13298

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48994 H-SIINF^EKL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".